Horizon Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.8M | Buy |
57,355
+3,973
| +7% | +$4.06M | 0.75% | 23 |
|
|
2026
Q1 | $49.1M | Sell |
53,382
-1,827
| -3% | -$1.85M | 0.55% | 34 |
|
|
2025
Q4 | $59.3M | Buy |
55,209
+23,285
| +73% | +$22.3M | 0.75% | 20 |
|
|
2025
Q3 | $24.4M | Buy |
31,924
+5,801
| +22% | +$4.32M | 0.32% | 58 |
|
|
2025
Q2 | $20.4M | Buy |
26,123
+16,632
| +175% | +$12.9M | 0.32% | 52 |
|
|
2025
Q1 | $7.84M | Buy |
9,491
+559
| +6% | +$465K | 0.23% | 54 |
|
|
2024
Q4 | $6.9M | Buy |
8,932
+3,497
| +64% | +$2.9M | 0.2% | 57 |
|
|
2024
Q3 | $4.82M | Buy |
5,435
+2,345
| +76% | +$2.11M | 0.13% | 77 |
|
|
2024
Q2 | $2.8M | Sell |
3,090
-7,835
| -72% | -$6.27M | 0.08% | 129 |
|
|
2024
Q1 | $8.48M | Buy |
10,925
+650
| +6% | +$463K | 0.22% | 59 |
|
|
2023
Q4 | $5.98M | Buy |
10,275
+2,059
| +25% | +$1.2M | 0.17% | 69 |
|
|
2023
Q3 | $4.4M | Buy |
8,216
+366
| +5% | +$189K | 0.13% | 75 |
|
|
2023
Q2 | $3.67M | Buy |
7,850
+1,637
| +26% | +$687K | 0.11% | 79 |
|
|
2023
Q1 | $2.13M | Sell |
6,213
-4,056
| -39% | -$1.37M | 0.06% | 116 |
|
|
2022
Q4 | $3.75M | Buy |
10,269
+5,397
| +111% | +$1.91M | 0.11% | 90 |
|
|
2022
Q3 | $1.57M | Sell |
4,872
-11,329
| -70% | -$3.59M | 0.05% | 134 |
|
|
2022
Q2 | $5.24M | Sell |
16,201
-2,849
| -15% | -$855K | 0.17% | 61 |
|
|
2022
Q1 | $5.44M | Buy |
19,050
+313
| +2% | +$80.6K | 0.15% | 72 |
|
|
2021
Q4 | $5.15M | Buy |
18,737
+1,498
| +9% | +$380K | 0.15% | 74 |
|
|
2021
Q3 | $3.97M | Buy |
17,239
+3,958
| +30% | +$977K | 0.1% | 94 |
|
|
2021
Q2 | $3.04M | Sell |
13,281
-1
| -0% | -$201 | 0.09% | 110 |
|
|
2021
Q1 | $2.48M | Buy |
+13,282
| New | +$2.6M | 0.09% | 100 |
|
|
2020
Q4 | – | Sell |
-18,337
| Closed | -$2.7M | – | 262 |
|
|
2020
Q3 | $2.7M | Buy |
18,337
+2,487
| +16% | +$385K | 0.1% | 102 |
|
|
2020
Q2 | $2.59M | Buy |
15,850
+6,721
| +74% | +$1.03M | 0.06% | 136 |
|
|
2020
Q1 | $1.26M | Buy |
9,129
+2,143
| +31% | +$294K | 0.06% | 116 |
|
|
2019
Q4 | $918K | Buy |
6,986
+2,651
| +61% | +$307K | 0.04% | 178 |
|
|
2019
Q3 | $482K | Sell |
4,335
-2,031
| -32% | -$226K | 0.02% | 165 |
|
|
2019
Q2 | $705K | Buy |
6,366
+2,580
| +68% | +$304K | 0.02% | 198 |
|
|
2019
Q1 | $489K | Buy |
+3,786
| New | +$460K | 0.02% | 204 |
|
|
2018
Q3 | – | Sell |
-12,632
| Closed | -$1.08M | – | 279 |
|
|
2018
Q2 | $1.08M | Buy |
+12,632
| New | +$1.04M | 0.05% | 123 |
|
|
2018
Q1 | – | Sell |
-13,519
| Closed | -$1.08M | – | 219 |
|
|
2017
Q4 | $1.08M | Buy |
+13,519
| New | +$1.15M | 0.07% | 100 |
|
|
2017
Q1 | – | Sell |
-11,581
| Closed | -$852K | – | 184 |
|
|
2016
Q4 | $852K | Buy |
+11,581
| New | +$862K | 0.06% | 68 |
|
|
2016
Q3 | – | Sell |
-6,957
| Closed | -$548K | – | 141 |
|
|
2016
Q2 | $548K | Buy |
+6,957
| New | +$524K | 0.04% | 78 |
|
|
2015
Q1 | – | Sell |
-42,763
| Closed | -$2.95M | – | 126 |
|
|
2014
Q4 | $2.95M | Buy |
42,763
+2,188
| +5% | +$148K | 0.3% | 32 |
|
|
2014
Q3 | $2.63M | Buy |
40,575
+4,909
| +14% | +$311K | 0.27% | 30 |
|
|
2014
Q2 | $2.22M | Buy |
35,666
+5,321
| +18% | +$317K | 0.27% | 41 |
|
|
2014
Q1 | $1.79M | Buy |
30,345
+2,271
| +8% | +$127K | 0.23% | 40 |
|
|
2013
Q4 | $1.43M | Buy |
28,074
+8,635
| +44% | +$432K | 0.22% | 26 |
|
|
2013
Q3 | $978K | Buy |
+19,439
| New | +$1.02M | 0.23% | 30 |
|
Other funds holding LLY
Horizon Investments's LLY Position: Q2 2026 in Review
Horizon Investments increased its Eli Lilly (LLY) stake by 7.4% in Q2 2026, buying an estimated $4.06M and bringing the position to 57,355 shares worth $68.8M. The position accounts for 0.75% of the portfolio, ranked #23.
Horizon Investments first reported a position in LLY in Q3 2013 and has held it in 39 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Horizon Investments held 57,355 shares of Eli Lilly worth $68.8M as of Q2 2026.
- Horizon Investments bought 3,973 Eli Lilly shares in Q2 2026, an estimated $4.06M.
- Eli Lilly made up 0.75% of Horizon Investments's portfolio in Q2 2026, its #23 holding.
- Horizon Investments first reported a position in Eli Lilly in Q3 2013 and has held it in 39 quarters since.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.